OPA1 R445H mutation in optic atrophy associated with sensorineural deafness

Area of Science:

• Genetics
• Neuroscience
• Ophthalmology
• Audiology

Background:

• Optic atrophy and sensorineural deafness are debilitating conditions.
• The OPA1 gene is implicated in mitochondrial dynamics and function.
• Understanding the genetic basis of these conditions is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate the role of OPA1 mutations in patients presenting with optic atrophy and deafness.
• To explore the underlying cellular mechanisms, particularly mitochondrial function, associated with these mutations.

Main Methods:

• Genetic analysis to identify OPA1 mutations in affected patients.
• Audiometry to assess hearing loss and characterize the type of deafness.
• Analysis of skin fibroblasts to evaluate mitochondrial network structure, membrane potential, and ATP synthesis.
• Immunohistochemical analysis of OPA1 expression in guinea pig cochlear cells.

Main Results:

• A heterozygous R445H mutation in OPA1 was identified in five patients with optic atrophy and deafness.
• Audiometry indicated auditory neuropathy as the cause of sensorineural deafness.
• Patient fibroblasts exhibited mitochondrial hyperfragmentation, reduced membrane potential, and impaired ATP synthesis.
• OPA1 expression was detected in sensory and neural cochlear cells of guinea pigs.

Conclusions:

• The OPA1 R445H mutation is associated with a syndrome of optic atrophy and sensorineural deafness.
• Mitochondrial network fragmentation and energy production defects are likely mechanisms underlying these clinical manifestations.
• OPA1 plays a significant role in the function of cochlear sensory and neural cells, linking mitochondrial health to hearing.